BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis
USA - NYSE:BLCO - CA0717051076 - Common Stock
15.07 USD
+0.51 (+3.5%)
15.07 USD
0 (0%)
BLCO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLCO was profitable.
BLCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of BLCO (-2.21%) is better than 69.68% of its industry peers.
BLCO has a Return On Equity of -4.74%. This is in the better half of the industry: BLCO outperforms 70.21% of its industry peers.
With a decent Return On Invested Capital value of 0.76%, BLCO is doing good in the industry, outperforming 66.49% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLCO is significantly below the industry average of 8.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROIC | 0.76% |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
1.3 Margins
Looking at the Operating Margin, with a value of 2.31%, BLCO is in the better half of the industry, outperforming 67.55% of the companies in the same industry.
BLCO's Operating Margin has declined in the last couple of years.
BLCO's Gross Margin of 59.45% is in line compared to the rest of the industry. BLCO outperforms 58.51% of its industry peers.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.31% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% |
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
BLCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BLCO has more shares outstanding
The number of shares outstanding for BLCO has been increased compared to 5 years ago.
Compared to 1 year ago, BLCO has a worse debt to assets ratio.
2.2 Solvency
BLCO has an Altman-Z score of 0.80. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
BLCO's Altman-Z score of 0.80 is in line compared to the rest of the industry. BLCO outperforms 52.13% of its industry peers.
BLCO has a Debt/Equity ratio of 0.77. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
BLCO has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: BLCO underperforms 72.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.8 |
ROIC/WACC0.1
WACC7.47%
2.3 Liquidity
BLCO has a Current Ratio of 1.51. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BLCO (1.51) is worse than 76.60% of its industry peers.
A Quick Ratio of 0.98 indicates that BLCO may have some problems paying its short term obligations.
With a Quick ratio value of 0.98, BLCO is not doing good in the industry: 79.26% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.51%.
Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.23% in the last year.
BLCO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.87% yearly.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
3.2 Future
The Earnings Per Share is expected to grow by 24.18% on average over the next years. This is a very strong growth
BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.94% yearly.
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 35.05, the valuation of BLCO can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 70.74% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.07. BLCO is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 19.06, BLCO is valued on the expensive side.
BLCO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 79.79% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.08, BLCO is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.05 | ||
| Fwd PE | 19.06 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 76.60% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.04 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BLCO's earnings are expected to grow with 18.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.93%
EPS Next 3Y18.02%
5. Dividend
5.1 Amount
No dividends for BLCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.07
+0.51 (+3.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.05%
Inst Owner Change7.26%
Ins Owners0.44%
Ins Owner Change9.85%
Market Cap5.34B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target15.43 (2.39%)
Short Float %8.31%
Short Ratio6.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.53%
PT rev (3m)-1.34%
EPS NQ rev (1m)-1.56%
EPS NQ rev (3m)-1.55%
EPS NY rev (1m)1.62%
EPS NY rev (3m)11.23%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.05 | ||
| Fwd PE | 19.06 | ||
| P/S | 1.07 | ||
| P/FCF | N/A | ||
| P/OCF | 31.57 | ||
| P/B | 0.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.04 |
EPS(TTM)0.43
EY2.85%
EPS(NY)0.79
Fwd EY5.25%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.48
OCFY3.17%
SpS14.05
BVpS18.16
TBVpS-4.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROCE | 0.96% | ||
| ROIC | 0.76% | ||
| ROICexc | 0.78% | ||
| ROICexgc | 2.5% | ||
| OM | 2.31% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% | ||
| FCFM | N/A |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.06 | ||
| Cap/Depr | 85.28% | ||
| Cap/Sales | 7.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 31.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.8 |
F-Score4
WACC7.47%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%
EBIT growth 1Y-39.47%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year45.28%
EBIT Next 3Y21.2%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%
BAUSCH + LOMB CORP / BLCO FAQ
What is the fundamental rating for BLCO stock?
ChartMill assigns a fundamental rating of 2 / 10 to BLCO.
What is the valuation status for BLCO stock?
ChartMill assigns a valuation rating of 2 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Overvalued.
Can you provide the profitability details for BAUSCH + LOMB CORP?
BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.
What is the valuation of BAUSCH + LOMB CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO) is 35.05 and the Price/Book (PB) ratio is 0.83.
Can you provide the financial health for BLCO stock?
The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.